Last updated on Mar 11, 2016
Get the free Investigational New Drug Application
We are not affiliated with any brand or entity on this form
Fill out
Complete the form online in a simple drag-and-drop editor.
eSign
Add your legally binding signature or send the form for signing.
Share
Share the form via a link, letting anyone fill it out from any device.
Export
Download, print, email, or move the form to your cloud storage.
Why pdfFiller is the best tool for your documents and forms
End-to-end document management
From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.
Accessible from anywhere
pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.
Secure and compliant
pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
What is IND Application
The Investigational New Drug Application is a regulatory document used by sponsor-investigators to request FDA approval for clinical trials of new drugs.
pdfFiller scores top ratings on review platforms
Who needs IND Application?
Explore how professionals across industries use pdfFiller.
IND Application is needed by:
-
Pharmaceutical companies preparing clinical trials
-
Research institutions conducting drug studies
-
Clinical trial sponsors and investigators
-
Regulatory affairs professionals
-
Medical researchers applying for drug approval
-
Compliance officers ensuring FDA regulatory adherence
Comprehensive Guide to IND Application
What is the Investigational New Drug Application?
The Investigational New Drug Application (IND) is a crucial regulatory document for obtaining FDA approval for new drugs. This application is submitted by a sponsor-investigator, who is responsible for overseeing the clinical trial process. One essential component of the IND application process is FDA Form 1571, which provides necessary details about the proposed study drug and its investigational use.
Purpose and Benefits of the Investigational New Drug Application
The IND application serves as a gateway to initiate clinical trials for new drugs, ensuring regulatory compliance and promoting patient safety. By including structured preclinical data and research plans, the IND not only facilitates the approval process but also emphasizes the importance of demonstrating the drug's efficacy and safety. This structured approach is critical in securing permission for clinical trials.
Who Needs the Investigational New Drug Application?
Various entities may require the IND application, particularly those involved in drug development such as pharmaceutical companies and researchers. The primary role of the sponsor-investigator is to complete the IND, which entails meeting specific eligibility criteria and prerequisites. Understanding these requirements is vital for all stakeholders in the drug development process.
How to Fill Out the Investigational New Drug Application Online
Filling out the IND application online involves several steps that require careful attention to detail. First, gather all necessary information, such as the sponsor-investigator's name and study drug name. Users will encounter various blank fields and checkboxes, including sections for the protocol number and funding information. Utilizing tools like pdfFiller can greatly simplify this process by providing features that facilitate form completion.
Field-by-Field Instructions for the Investigational New Drug Application
Completing each section of the IND application necessitates understanding specific instructions and requirements. Major sections include:
-
Chemistry and manufacturing data
-
Clinical research plan
-
Pharmacological data
Accurate and complete data submission is crucial to avoid common errors that can lead to application rejections. Attention to detail in these sections is essential for a successful submission.
Submission Process for the Investigational New Drug Application
The submission process for the IND application can be accomplished through either online or paper submission methods. Applicants must know where to send their completed forms and any associated fees. Additionally, understanding how to confirm and track submission status is critical for maintaining oversight during the application process.
Security and Compliance for the Investigational New Drug Application
Ensuring data protection is paramount in the IND application process. Security measures, such as 256-bit encryption offered by platforms like pdfFiller, are essential for safeguarding sensitive information. Compliance with FDA regulations and maintenance of privacy during data handling further reinforce the trustworthiness of the application process.
What Happens After You Submit the Investigational New Drug Application?
Once submitted, the IND application enters a review process by the FDA, which can involve varied timelines. Applicants should be prepared to amend or correct their submissions if necessary. Understanding common reasons for rejection can help applicants proactively address potential issues in their applications.
How pdfFiller Supports Your Investigational New Drug Application Needs
pdfFiller offers valuable features that enhance the process of completing the IND application. These features streamline filling, editing, and eSigning, making the application more efficient. User testimonials highlight successful submissions facilitated by pdfFiller's capabilities in document sharing and collaboration.
Start Your Investigational New Drug Application with pdfFiller!
Getting started with pdfFiller is straightforward and allows users to experience the benefits of a cloud-based solution for their IND applications. Resources and support are readily available, making the form filling process manageable and efficient for all users.
How to fill out the IND Application
-
1.To access the Investigational New Drug Application form on pdfFiller, navigate to the website and use the search feature to find the specific form.
-
2.Open the form by clicking on the link, which will direct you to the pdfFiller editing interface.
-
3.Before starting to fill out the form, gather all required information such as study drug details, sponsor-investigator's name, protocol number, and funding specifics.
-
4.Once you have the necessary information, begin filling out the blank fields marked in the form, making sure to complete all sections accurately.
-
5.For fields requiring specific data, such as 'Insert the Name of the Sponsor-Investigator', write the requested information in the provided blanks.
-
6.Utilize pdfFiller's tools to highlight important instructions like 'Insert completed FDA Form 1571 Here' to ensure you do not overlook essential requirements.
-
7.Check each section of the table of contents to confirm all required information is filled in, including pharmacology and toxicology details.
-
8.After completing all fields, review the information for accuracy and completeness, ensuring that all required signatures are included.
-
9.Once you finalize the document, you can save your changes, download the completed form in your preferred format, or submit it directly through pdfFiller.
Who is eligible to submit an Investigational New Drug Application?
Eligible applicants include sponsor-investigators, which typically are individuals or entities proposing to conduct clinical trials for new drugs. Ensure you have the necessary qualifications and institutional support.
What is the deadline for submitting this application?
There are no fixed deadlines for IND applications; however, it is recommended to submit this application well before the intended start date of the clinical trial to allow for FDA review time.
How do I submit the completed Investigational New Drug Application?
The completed IND application can be submitted electronically to the FDA via the Electronic Submissions Gateway (ESG) or by mail depending on the specific requirements and guidelines provided by the FDA.
What supporting documents are required for this application?
Supporting documentation typically includes preclinical data, clinical research plan details, drug manufacturing information, and any other relevant studies or data supporting the application. Ensure thoroughness in documentation.
What are common mistakes to avoid when filling out the IND application?
Common mistakes include failing to complete all required sections, omitting essential signatures, or submitting incomplete supporting documents. Double-check all fields and consult FDA guidelines to minimize errors.
How long does it take for the FDA to process an IND application?
The FDA aims to process IND applications within 30 days to confirm safety and compliance. However, complex applications may require additional time, and communication from the FDA will indicate any further requirements.
What concerns should I keep in mind when preparing my application?
Ensure all provided information is accurate and comprehensive. Special attention should be given to the clarity of the clinical trial design, as well as the quality of the preclinical data supporting the IND application.
Related Forms
Get the latest insights from our blog
If you believe that this page should be taken down, please follow our DMCA take down process
here
.
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.